Evaluating the impact of Pap smear screening on cervical cancer prevention in tribal women
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20253681Keywords:
PAP smears, Cervical cancer, Tribal women, Early- diagnosis, ScreeningAbstract
Background: Cervical cancer is one of the most preventable cancers, yet it remains a major cause of morbidity and mortality in tribal communities due to limited access to healthcare and poor screening uptake. Early detection through Pap smear screening significantly reduces the disease burden.
Methods: A community-based cross-sectional study was conducted from January 2022 to December 2022 at Dr. N. Y. Tasgaonkar Institute of Medical Science (NYTIMS), Karjat, Maharashtra, India, to assess the impact of Pap smear screening on cervical cancer prevention in tribal women aged 25-65 years. Demographic data, screening participation, and follow-up outcomes were collected and analyzed.
Results: Of 1,000 eligible women, 750 (75%) underwent Pap smear screening. Participation was influenced by age, education, and prior health education. Among screened women, 85% had normal results, 12% had minor cytological abnormalities, and 3% showed significant precancerous changes requiring further management. Cervical cancer incidence decreased by 35%, and mortality was 50% lower among the screened population.
Conclusions: Pap smear screening substantially reduces cervical cancer incidence and mortality in tribal populations. Improving awareness, addressing cultural barriers, and expanding mobile screening services are critical to increasing participation and ensuring timely intervention.
Metrics
References
World Health Organization. Global Cancer Observatory: Cervical Cancer, 2020. Available at: https://gco.iarc.fr/en. Accessed 01 June 2025.
ICO/IARC Information Centre on HPV and Cancer. India Human Papillomavirus and Related Cancers, Fact Sheet, 2023. Available at: https://hpvcentre.net/statistics/reports/IND_FS.pdf. Accessed 01 June 2025.
Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med. 2008;5(6):e132. DOI: https://doi.org/10.1371/journal.pmed.0050132
Singh A, Patra S, Pati S. Barriers to cervical cancer screening among tribal women in India: a cross-sectional study. Indian J Community Med. 2020;45(3):312-7.
Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79(10):954-62.
Shastri SS, Mittra I, Mishra GA, Gupta S, Dikshit R, Singh S, Badwe RA. Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J Natl Cancer Inst. 2014;106(3):dju009. DOI: https://doi.org/10.1093/jnci/dju009
Basu P, Mittal S, Banerjee D, Singh P, Panda C, Dutta S. Diagnostic accuracy of human papillomavirus testing in primary cervical screening in rural India. Int J Cancer. 2015;137(4):954-62. DOI: https://doi.org/10.1002/ijc.29458
Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in developing countries. Best Pract Res Clin Obstet Gynaecol. 2012;26(2):193-202. DOI: https://doi.org/10.1016/j.bpobgyn.2011.08.001
Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N. European guidelines for quality assurance in cervical cancer screening. Int J Cancer. 2020;146(5):1184-91.
Gupta R, Singh D, Bhatia N. Awareness and uptake of Pap smear screening in rural women of North India. Asian Pac J Cancer Prev. 2021;22(4):1125-30.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates. CA Cancer J Clin. 2018;68(6):394-424. DOI: https://doi.org/10.3322/caac.21492
Sauvaget C, Fayette JM, Muwonge R, Wesley R, Sankaranarayanan R. Accuracy of conventional cytology for cervical cancer screening: a systematic review. Acta Cytol. 2011;55(6):555-67.
Downloads
Published
How to Cite
Issue
Section
